Stock BRPA NRX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus NRx Pharmaceuticals, Inc.

Equities

BRPA

US6294442099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.54 USD +12.74% Intraday chart for NRx Pharmaceuticals, Inc. +16.45% -23.04%
Apr. 18 NRx Pharmaceuticals Receives Notice of Listing Compliance From Nasdaq MT
Apr. 18 Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of Fed Policymakers Speeches MT

Evolution of the average Target Price on NRx Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9dcc982c8.KO-G1q9t5hCv9738QN4CFHKUjaMy93kwrguWWV4pcU4.SqPN4O1Yy1nCg_OIAbttZBug-dtIshd3_2_ULmxsRiRcl8OlzV3RRPqS8A~cb9638538e4c332610e62816764b85ce

Analyst Recommendations on NRx Pharmaceuticals, Inc.

Ascendiant Capital Starts NRX Pharmaceuticals at Buy With $4 Price Target MT
HC Wainwright Starts NRX Pharmaceuticals at Buy With $2 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.54 USD
Average target price
37.5 USD
Spread / Average Target
+959.32%
High Price Target
55 USD
Spread / Highest target
+1,453.67%
Low Price Target
20 USD
Spread / Lowest Target
+464.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering NRx Pharmaceuticals, Inc.

Ascendiant Capital
HC Wainwright

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BRPA Stock
  4. Consensus NRx Pharmaceuticals, Inc.